×
AbbVie Revenue 2010-2024 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie revenue for the twelve months ending December 31, 2024 was
$56.334B
, a
3.71% increase
year-over-year.
AbbVie annual revenue for 2024 was
$56.334B
, a
3.71% increase
from 2023.
AbbVie annual revenue for 2023 was
$54.318B
, a
6.44% decline
from 2022.
AbbVie annual revenue for 2022 was
$58.054B
, a
3.3% increase
from 2021.
View More
AbbVie Revenue 2010-2024 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie annual revenue for 2024 was
$56.334B
, a
3.71% increase
from 2023.
AbbVie annual revenue for 2023 was
$54.318B
, a
6.44% decline
from 2022.
AbbVie annual revenue for 2022 was
$58.054B
, a
3.3% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$823.1B
Johnson & Johnson (JNJ)
$380.1B
Novo Nordisk (NVO)
$374.3B
Roche Holding AG (RHHBY)
$259.5B
Novartis AG (NVS)
$218.5B
Merck (MRK)
$216.5B
Pfizer (PFE)
$146.7B
Sanofi (SNY)
$136B
Bayer (BAYRY)
$22B
Innoviva (INVA)
$1.1B